MCM7 and hepatocellular carcinoma: Compared with patients with both low MCM7 and low cyclin D1 expression, others were at a higher risk of death from HCC during the study (adjusted HR (95% CI): 2.57 (1.61–4.10), P<0.001) (Table 2 and Supplementary Table S2).